chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Really bad headache; "moody aches"; "moody aches"; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0170) via an unspecified route of administration on 17Apr2021 at 14:30 (at the age of 58-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. the patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included amlodipine from an unknown date for an unknown indication. On 17Apr2021 the patient experienced a really bad headache and "moody aches" the first 24 hours after injection. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of headache and "moody aches" were recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
pain at the injection site; More than 35 days between Covid-19 vaccinations; dizzy spell which passed after a day; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy spell which passed after a day), VACCINATION SITE PAIN (pain at the injection site) and PRODUCT DOSE OMISSION ISSUE (More than 35 days between Covid-19 vaccinations) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy spell which passed after a day), VACCINATION SITE PAIN (pain at the injection site) and PRODUCT DOSE OMISSION ISSUE (More than 35 days between Covid-19 vaccinations). At the time of the report, DIZZINESS (dizzy spell which passed after a day) and PRODUCT DOSE OMISSION ISSUE (More than 35 days between Covid-19 vaccinations) had resolved and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  No treatment medication were provided.  Patient did not go back to receive her second Moderna Covid-19 vaccine from her Physician.  Reporter asked whether patient can receive her second Moderna covid-19 vaccine 3 months after receiving her first Moderna Covid-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jan-2022: Non-significant follow up contains no new information.
employee has had severe body aches and malaise since the day of vaccine.  Three days post-vaccine she is marginally improved, but left deltoid where injection was given is warm to the touch; however she states that to move the arm causes severe muscle pain.  There is no redness noted; employee denies ever being febrile
HYPOTENSION 10/20/2022 HYPOTENSION HYPOXIA 11/9/2022 HYPOTENSION
Patient was very nervous after the vaccine, anxious as usual, accompanied by her MOther (Mother called 911) Patient appeared to faint for a few seconds, and back to normal at 1240PM patient stable
Patient seen in clinic today 4/29/22 and diagnosed with shingles on right upper shoulder neck
nausea, headache, injection site pain, body aches,  chills, fatigue
They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday; They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer (patient) reported similar events for 2 patients. This is the first of two reports.   The female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE  DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported "They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday on 23Jan2021. Asking if they should still take the 2nd dose of the vaccine." The patient underwent lab tests and procedures which included test (sars-cov-2 test): positive on 23Jan2021. The outcome of the events was unknown.  No follow-up attempts possible. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021106620 Same reporter, same product. same event, different patient
Severe skin allergic reaction, burning sensation, skin lesions, skin feels rough like sandpaper, itchy and burning, skin looks bruised everywhere it folds.
side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment medications were reported   Reporter did not allow further contact
No known adverse even at this time. MMRV was given at the same time as Varicella.  MMR should have been with Varicella as the first dose in the series. The child essential received extra dosing of the Varicella vaccine.
his heart rate didn't go below 89; cold chills; very tired; lack of energy; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN) and clopidogrel bisulfate (PLAVIX). Historical vaccine includes first dose of BNT162B2 for covid-19 immunization and experienced no side effects. The patient reported, he received the second dose of Covid 19 vaccine on Thursday, he takes aspirin and Plavix regularly, he took them the morning he received the vaccine, the following day he had cold chills, was feeling very tired, and lack of energy, his heart rate didn't go below 89, it lasted one day. On Friday he was dried out, on Saturday he started to feel better and on Sunday his heart rate was on 70s-60s. The patient underwent lab tests and procedures which included heart rate: didn't go below 89, heart rate: 70s-60s on an unspecified date. Outcome of events was unknown.  Follow-up attempts completed. No further information expected.
High blood pressure; Vertigo; Headache; flu like symptoms (just as she did with the second dose); Immune system has been overstimulated; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), VERTIGO (Vertigo), INFLUENZA LIKE ILLNESS (flu like symptoms (just as she did with the second dose)), IMMUNE SYSTEM DISORDER (Immune system has been overstimulated) and HEADACHE (Headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised. Concomitant products included PEGINTERFERON ALFA-2A (PEGASYS) from an unknown date to 08-Sep-2021 for Immunocompromised, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM and PROGESTERONE for an unknown indication.    On 01-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms (just as she did with the second dose)) and IMMUNE SYSTEM DISORDER (Immune system has been overstimulated). On 04-Sep-2021, the patient experienced HYPERTENSION (High blood pressure), VERTIGO (Vertigo) and HEADACHE (Headache). At the time of the report, HYPERTENSION (High blood pressure) and VERTIGO (Vertigo) had not resolved and INFLUENZA LIKE ILLNESS (flu like symptoms (just as she did with the second dose)), IMMUNE SYSTEM DISORDER (Immune system has been overstimulated) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Antibody test: high (High) titers were high. On an unknown date, Blood pressure measurement: low (Low) used to be low before the third dose.         The patient was a classic example of someone who was small. Before receiving third dose, the patient asked her doctor to do her antibody test again, but doctor told they didn't believe in Ab testing. The patient still had high BP and vertigo. The doctors told the patient to stay hydrated.   On 13-Sep-2021, the patient went to a specialist the vertigo and she was given some exercises but that got her worse, so she had stopped them.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-320592 (Patient Link).
WHELPS AND RASH BROKE OUT ON ARMS, LEGS, ABDOMEN, SEVERE ITCHING.
Vaccine administered after the expiration date of 04/28/2021. Patient reported no adverse events.
Patient received vaccine past the six hour expiration date; A spontaneous report was received from a nurse concerning a patient who received MODERNA's COVID-19 vaccine (mRNA-1273) and the patient received vaccine past the six hour expiration date.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 31 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025L20A) intramuscularly for prophylaxis of COVID-19 infection.   On 31 Dec 2020, the patient received an mRNA-1273 vaccine dose that was past the six-hour expiration date. The first dose from the vial had been administered more than six hours before the patient received their dose. The patient did not experience any adverse events. Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not reported.  The event, patient received vaccine past the six hour expiration date, was considered resolved on 31 Dec 2020.; Reporter's Comments: This report refers to a case of out of specification product use for mRNA-1273, lot # 025L20A. There were no reported adverse events associated with this case of out of specification product use.
2 days after my initial vaccine injection, my lower body joints/muscles/tendons were extremely painful to move. The pain was evident after sitting or laying down for 10+ minutes. During nighttime sleep, the pain does not allow me to move my lower extremities without intense pain keeping me awake and only allowing less than 2 hours of sleep a night. Prior to March 12, I was physically fit and active. I was able to ride a stationary bike, treadmill and attend fitness classes. Now, I need to walk with a cane and I was diagnosed with "arthritis" symptoms as well as micro tears in my left knee. My left knee swells so much that I am unable to bend it without great pain.
I developed a rash from my thighs, up my torso (front and back), my neck, and my face. The rash lasted for more than 48 hours. I used Benadryl to ease the itching, but it did not reduce the inflammation. I also experienced dizziness, shaking in my hands and jaw, and foggy headed feeling. These symptoms lasted only a little more than 24 hours.
4/22 Pt. walked in to doctor's office         c/o swelling around outside         harder with Left breast & Left         axillary area with pain. Left upper         arm warm and swollen
Patient reports her arm looks red and puffy (flat shaped area the size of a small lemon) that is warm and itchy. She also reports small spots that are flat and red around this area the size of a pencil eraser. She reports this today, 10/4/23.
SEVERE SHARP PAINS IN JOINTS, THEN BY 07:00 am NAUSEA, ABDOMINAL PAIN, CHILLS. OVER NEXT 3 DAYS CONTINUED CHILLS, LOW GRADE FEVER, SORE THROAT SINUS CONGESTION AND MUSCLE/ JOINT PAINS
CHIEF COMPLAINT:   Pt scheduled for thoracentesis Monday, usually gets tapped Qmonth. Under treatment for lung cancer. Patient states he is having a hard time breathing and needed to come in for thoracentesis.   HISTORY OF PRESENT ILLNESS:     61-year-old gentleman with a history of lung cancer presenting for evaluation of shortness of breath.  Patient reports progressive shortness of breath for the past 2 to 3 days.  He states that he has undergone thoracentesis twice in the past and the symptoms are similar to prior pleural effusions.  He denies chest pain.  He denies fever or cough.
The day after the vaccination, I was getting expected side effects (muscle soreness, fatigue and chills). I was not very concerned about this. 3 days after vaccination, I was getting hives on my body, most notably on my back. This persisted and I went to a dermatologist who diagnosed it as dermatographism. I have been taking allergy medicine to treat this based on my doctor's recommendation. It is now 3 months later and I am still experiencing dermatographism.
Mom describes child as "limp" "weak" just did not feel "solid" when she held him almost immediately after shots and through the evening - cried inconsolably for 6 hrs - would not eat for 8 hrs.
Pt recvd vax the evening of vax exp muscle twitching of both legs, both arms, face along w/h/a & nausea; events lasted about 3 days--resolved w/o any treatment;
Received the first dose of vaccine almost three weeks ago and developed COVID-19; illness; Received the first dose of vaccine almost three weeks ago and developed COVID-19; illness; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported similar events for two patients. This is the first of two reports.  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, in 2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient and her husband received the first dose of vaccine almost three weeks ago and developed COVID-19 on an unspecified date in 2021 and their primary doctor said to delay second shot because of illness. The patient wanted to know if this was okay. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021331422 Same reporter, drug, and events; different patient
STOMACH ISSUES; HEADACHES; NAUSEA; This spontaneous report received from a consumer concerned a 55 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced stomach issues, headaches, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headaches, stomach issues, and nausea. This report was non-serious.
Felt the Side Effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt the Side Effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION COMPLICATION (Felt the Side Effects). At the time of the report, VACCINATION COMPLICATION (Felt the Side Effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Quote from patient email:  "At ~ 0845, began to experience tightness-type sensation in my throat, difficult to accurately describe but it was associated with a left jaw pain, somewhat of a dull ache. Because of the aching radiating to my jaw, I felt it was in my best interest to go to the ED for evaluation. While walking to the ED, the sensation in the throat, and the aching in left jaw subsided, but then recurred shortly afterwards. I subsequently had EKG's, labs, and stress echo, all of which were normal. I mentioned to the ED physicians throughout my thoughts that this was a reaction to the vaccine, and still believe this to be the case."
This spontaneous report as received from a female patient of unknown age with arthritis in spine, leaky valve and "blood pressure" refers to herself. In July 2013 the patient had already had a case of shingles. During that case of the shingles, she also had a sinus infection, where she was treated with KEFLEX. patient also stated that many years ago, she had hives after taking an unspecified "sulfa" product. On 06-AUG-2013 the patient was vaccinated with a dose of ZOSTAVAX (route, dose and lot# were unknown). Concomitant therapies included INDERAL LA, amlodipine besylate, hydrochlorothiazide, TRIBENZOR, meloxicam, tramadol hydrochloride and VALIUM. On 16-APR-2014, the patient was again diagnosed with the shingles on her right backside. The patient was treated with generic RELAFEN. The patient mentioned that a week before the second shingles case, she went through Electromyography (EMG) and conduction velocities (CV) tests in the lumbar area of the spine. She thought this could be a correlation. The patient said that her recent blood tests (on an unknown date of 2014) show estimated glomerular filtration rate (eGFR) was lower, creatine was high and glucose was higher than usual. The outcome of events was unknown. The ZOSTAVAX was not reintroduced. Additional information has been requested.
Itching swelling rash on hand and palms. Swelling palms Swelling lips Scratchy throat
My arm was sore. Then I had fatigue and then at about 14 hours after the injection, I started having chills - like I had temperature with hot and cold chills. I got very cold; my blood pressure dropped - I happened to have a doctor appt the day following the vaccine - the bottom level was very low of my blood pressure - it was 45. I couldn't warm up - my extremities were very cold. I had chest pain and it felt like my heart rate was going in an out of atrial fibulation. I had shortness of breath. I measured my blood oxygen concentration and had dropped down to 90%. I didn't sleep well because I was so chilled and not feeling well. I felt like I had a bad flu. I rested the next day (10th) the symptoms slowly went away between 10 am and 1:00. At 3:00 pm, I saw my pain doctor and I told him about it but I was feeling much better although blood pressure was low. Fatigue lasted for 3-5 days afterwards but it wasn't anything last the first 24 hours. I didn't go to ER because it seemed to resolve itself in the day.
The physician that administered the initial vaccination did not have any vaccine in the needle, thus inserting air into the patient. The physician recognized his mistake then re-vaccinated the patient.
Information has been received from a lawyer regarding a case in litigation concerning an elderly female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2016, at approximately 68 years old, the patient was administered the ZOSTAVAX by a pharmacist at a pharmacy. On an unknown date, the patient was treated by a healthcare provider at a hospital for the following injury resulting from her ZOSTAVAX use: Bell's palsy. The outcome of the Bell's palsy is unknown. The patient claims damages as a result of: injury to herself, loss of consortium, loss of services, and economic losses. Upon internal review, Bell's palsy was determined to be medically significant. Additional information has been requested.
No adverse event. Patient given adult Pfizer (12 and above) instead of pediatric Pfizer (for 5 to 11). Patient was 2 days shy of turning 12 years old. Dose 1 was given on 11/01/2021. Patient turned 12 on 11/03/2021. No adverse events reported. Patient was observed for 15 minutes without any issues. Patient got adult Pfizer dose 2 on 12/13/2021 since he was already 12 at the time. No adverse events.
Fever; 2cm Localized erythema and edema at injection site right thigh; 3-5mm erythema at 1 site left thigh
Fever of 103, severe weakness, dizziness, nausea, unable to walk down stairs due to weakness.
On 1/7 (post-vaccination day 1) patient awoke with malaise, febrile with generalized weakness and chills. Slept most of the day, peak temperature 102.5F. Consulted employee health, advised to get COVID tested - which was negative. On 1/8 (post-vaccination day 2) patient felt somewhat better with improved energy, still febrile to 101.5.   Symptoms were treated with acetaminophen 650mg q6h PRN. Pt was able to return to work on post-vaccine day 3, continued to take acetaminophen PRN until post-vaccine day 6. She continued to have some generalized malaise, which resolved by post-vaccine day 14. ---- Of note, the patient has dermatomyositis, for which she normally takes azathioprine 150mg daily. This was held starting on 12/18/2020 on advice of her rheumatologist, with the thinking being to optimize the immune response for COVID vaccination. First dose of Pfizer was on 12/18. So the patient was off her immunosuppression, when she received the second dose and experienced the adverse event.
Slightly larger than golf ball sized swelling and redness at injection site. Swelling and redness only at injection site, no pain or reactions anywhere else.
pt recvd flu vax & approx 3-4 hrs later noticed redness of the entire upper arm, accompanied by warmth; applied ice to affected area & the reaction subsided;
Client was 12 years old and received a pediatric 0.2 ML dose of Pfizer vaccine. Client then received an appropriate  12+ 0.3 mL dose of the Pfizer vaccine. The next morning the client has a sore arm and received Ibuprofen, which was effective.  The client reports no further or worsening symptoms.